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Abstract
Analysis of biological processes is frequently performed with the help of phenotypic assays where data is mostly acquired in
single end-point analysis. Alternative phenotypic profiling techniques are desired where time-series information is essential
to the biological question, for instance to differentiate early and late regulators of cell proliferation in loss-of-function
studies. So far there is no study addressing this question despite of high unmet interests, mostly due to the limitation of
conventional end-point assaying technologies. We present the first human kinome screen with a real-time cell analysis
system (RTCA) to capture dynamic RNAi phenotypes, employing time-resolved monitoring of cell proliferation via electrical
impedance. RTCA allowed us to investigate the dynamics of phenotypes of cell proliferation instead of using conventional
end-point analysis. By introducing data transformation with first-order derivative, i.e. the cell-index growth rate, we
demonstrate this system suitable for high-throughput screenings (HTS). The screen validated previously identified inhibitor
genes and, additionally, identified activators of cell proliferation. With the information of time kinetics available, we could
establish a network of mitotic-event related genes to be among the first displaying inhibiting effects after RNAi knockdown.
The time-resolved screen captured kinetics of cell proliferation caused by RNAi targeting human kinome, serving as a
resource for researchers. Our work establishes RTCA technology as a novel robust tool with biological and pharmacological
relevance amenable for high-throughput screening.
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Introduction
RNA interference has developed into a powerful technology for
high-throughput screening. Numerous studies have uncovered novel
functions of genes in biological processes within a number of species
and conditions. However, most studies have used single end-point
analysis as readout for the characterization of the respective
phenotypes [1,2,3,4,5,6,7,8,9]. An end-point analysis provides merely
a ‘‘snapshot’’ of the respective analyzed phenotype, neglecting its
development over time. Moreover, in many studies pre-labeling,
fixation or cell destruction is required prior to the assay. Few screens
have been performed, mostly using high-content screening micros-
copy, where cellular phenotypes were detected with time resolution
[10,11,12,13,14]. However, even there the timing of events was
mostly not considered. Recently, real-time and label-free monitoring
ofcellproliferationthatisbased onelectricalimpedancereal-timecell
analysis (RTCA) has become available and is just starting to be
employed in phenotypic analyses of perturbed cells [13].
The RTCA system is based on the fact that cell membranes
consist of a lipid bilayer having high electrical resistance, and
that the adhesion of cells can be steadily detected by the gold
micro-electrodes at the bottom of wells with electrical impedance as
read-out [15,16,17]. The strength of impedance is positively
correlated with the numberofcells having attached to theelectrodes
and is recorded as cell index (CI) values (Figure S1a). Among other
factors, the impedance mainly refects the attached cell number as
well as the quality of the cells’ interaction with their substrate [10].
Therefore, this method is suitable for quantifying cell proliferation
without the need for tagging or modifying the sampled cells, as
shown in other technologies relying on cell-impedance [18].
We have exploited such a system to collect continuous and
quantitative information on the changes in the electrical impedance
that are imposed by RNAi-induced knockdown of genes. Since
human kinases and cell cycle proteins are important for cell
proliferation and often employed as drug targets, we carried out a
human kinome RNAi screen to test the biological and pharmaco-
logical relevance of the RTCA system. In this study, we first
established impedance measurement as a novel, robust screening
tool to monitor cell proliferation by performing screening quality
controls (QC) after proper data transformation. Then we integrated
the RTCA system into a high-throughput workfow for siRNA
transfections. Subsequently, we utilized a human siRNA library
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22176targeting 779 kinases and 80 cell cycle genes to analyze cell
proliferation in real-time, and monitored the dynamics of the
cellular response to knockdown of the respective genes. The
obtained real-time profiles of the phenotypes provide novel, direct
insights into the dynamics of the knockdown of the involved genes
and proteins as well as their impact on the cell system.
Results
Cell impedance refects time-resolved cell proliferation
With the ability to analyze cell proliferation in a time-resolved
manner, we first determined the reproducibility and robustness of
the RTCA system. To test three known effectors of cell viability in
HeLa cells, PLK1 [19], WEE1 [20,21] and COPB2 [22], we
performed RNAi experiments in 18 biological replicates on six
individual microtiter plates. Knockdown of these positive controls
for cell proliferation inhibition indeed reproducibly induced a
strong reduction of the cell index (Figure 1a) when compared to a
non-targeting negative control (siAllStars). The RTCA data was
next validated utilizing a WST-1 quantitative colorimetric assay
that refects cell viability and proliferation [23]. Very similar
phenotypes were observed in the RTCA and WST-1 assays
(Figure 1b). The highly reproducible profiles of the positive and
negative controls suggest that the onset and dynamics of cellular
responses to knockdown of the respective genes are different and
specific for the individual targeted genes.
Data transformation with Cell-Index Growth Rate
The initial outputs from the commercial software shipped with
the RTCA system, the time-series cell index (CI), posed challenges
on data analysis that needed to be solved prior to being able to
analyze data from high-throughput screens, for instance the
reference time point has to be chosen arbitrarily, and the
measurement error accumulates at later time points (see Material
and Methods). As a solution we introduced the cell-index growth
rate (referred to as CIGR later) transformation, by transforming
cell index into the point-wise first-order derivative, i.e., the slope of
CI curve at each time point (see details in Material and Methods
and Figure S2). Analogous to the relationship between velocity
and distance in physics, CIGR is the rate of change of cell index
and describes the transient status of cell proliferation at any time.
The transformation overcomes main pitfalls of using cell index,
and we could show that the maximum CIGR in the exponential
cell-growth phase is linearly correlated with the cell number
(Figure S1b), therefore establishing CIGR as the measure of
transient cell proliferation. Figure 2a shows the cell-index growth
rate curves by transforming the data presented in Figure 1a. Major
differences in the growth characteristics are confined to the first
20–40 hours. The CIGR transformation does not only separate
apoptosis inducing siRNAs from the negative control, but also
distinguishes different time-kinetics between the cell proliferation
inhibitors more clearly. For example, the effect of COPB2
knockdown manifests at later time points (30–60 hours) compared
to PLK1 or WEE1, refected by continuous lower CIGR.
Time-dependent Z-factor establishes RTCA system as a
robust tool for high-throughput screening
In order to verify that RTCA is indeed suitable for high-
throughput screening, we next estimated time-dependent Z-factors
for the data obtained upon knocking down control genes (Material
and Methods). The time-dependent Z-factor curves (Figure 2b)
indicate that this factor equals or is stably greater than 0 over a
Figure 1. Time kinetics of cell growth after knock-down of indicated control genes and a negative control captured with RTCA
system and WST-1 assay. (a) The RTCA system monitors cell growth after transfection of non-targeting control (siAllStars) and cell-growth
inhibitors (COPB2, WEE1 and PLK1) from 8 hours up to 68 hours. It records the electrical impedance of growing cells and reports it as cell index. The
normalization has been performed according to the manufacturers instructions (Materials and Methods). Three time points at which the WST-1 assay
was performed in parallel experiments are indicated in dotted lines. Each curve represents one siRNA knockdown sample, and the error bars indicate
the standard deviation of individual cell impedance measurements (N 18). (b) WST-1 assay was performed with the same set of siRNA at 16, 40 and
64 hours respectively, supporting the profiles observed with RTCA system (N=18)
doi:10.1371/journal.pone.0022176.g001
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with each of the three positive control siRNAs. This shows that
RTCA indeed allows for the identification of time-resolved
significant hits in high-throughput screens. We also observed that
the time-windows of maximum effect sizes were shifted among
positive controls, indicating distinct kinetics of each gene, and
suggesting different time points at which the genes exert their
maximum effect on cell proliferation. Together, RTCA allows for
the identification of significant hits in real-time high-throughput
screens with data transformation.
Human kinome screen with the RTCA system identifies
inhibitors and activators of cell proliferation
Encouraged by the above results, we next performed a whole
human kinome screen. In this screen, we knocked down 779 kinases
as well as 80 cell cycle genes (referred to as kinases hereafter) in
HeLacells using siRNA libraries. Every knockdown was repeated in
two biological replicates with control genes and their biological
replicates positioned on each 96-well plate (Table S1).
In order to test for the presence of global trendsin the phenotypes
of kinome knockdown, we visualized the time-series CIGR for all
tested genes. This generated a population average over all
knockdown effects as well as standard deviation bars describing
the range of the effects for each time point (Figure 3a). The trend
line that was fitted to the data indicated that perturbed cells
continue growing, after having passed a lag phase that lasted for
about 30 hours post transfection. However, the majority of kinases
displayed weak inhibiting phenotypes as compared to the negative
control. In contrast, the COPB2 positive control was indeed a
strong inhibitor of cell proliferation as the CIGR did not pass the
zero line. Interestingly, both negative controls, as well as the
population average showed oscillation with a period of approx-
imately 17 hours. This had a strong amplitude at the beginning and
became weaker later on. This cycling might reflect the cell cycle
synchronization induced by the transfection procedure.
To allow for comparison of different siRNAs across plates, as
well as to compare the results of RTCA measurements with that
from conventional end-point analysis, we calculated the average
CIGR and normalized the data with the z-score method.
Normalization proved to efficiently overcome unspecific effects
that had not originated from target gene knock-down (Figure S3).
This conclusion is supported by the robustness analysis where the
separation of controls was monitored across the plates in the
screening order (Figure S4). The biological replicates of negative
and positive controls in most plates were well distinguished by
their z-score, indicative of the assay being robust.
The derived z-scores of average CIGR were used to identify
constant modulators of cell proliferation. Top hits from the screen
were identified by ranking the genes according to the absolute
values of the z-scores and selecting the upper 5% of the genes (i.e. all
|z| =1.96 equivalently p , 0.05, 45 genes in total). These were
clustered into inhibitors and activators of average cell proliferation,
respectively (Tables S2 and S3). Time-resolved data on CI and
CIGR for each siRNA are provided in Tables S1 and S4,
respectively. The average CIGR as well as the z-scores obtained
for all siRNAs tested in the screen are provided in Table S5. To test
the overlapping of hits with end-point analysis we determined to
Figure 2. Cell-index growth rate transformation and time-dependent Z-factors of siRNA screen with the RTCA system. (a) The point-
wise derivative transformation was applied to the raw data shown in Figure 1 (a), and we name the transformed measure as cell-index growth rate
(CIGR). The magnitude of CIGR (its absolute value) measures the transient cell growth rate and its direction (positive, negative and zero) indicates the
status of cell growth: in increasing, in recession or constant. Each siRNA sample is represented in one color, with dots indicating mean and error bars
indicating standard deviation (N=18). (b) Time-dependent Z-factors calculated with the data of subfigure (a). We have extended the classical Z-factor
into time-dependent Z-factor to allow presenting the effect sizes at different time points. The time-dependent Z-factor has been estimated for each
positive control of cell growth inhibition. For all the three positive controls, we observed at least one large time window in which the Z-factor is larger
than 0, indicating a very robust assay with siRNA. The shifting of these time windows reflects the fact that each positive control has its unique kinetics
and distinct time when the maximum effect is reached.
doi:10.1371/journal.pone.0022176.g002
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(Tables S6 and S7). We initially compared the list of siRNAs and
their respective target genes that had inhibited cell proliferation in
the RTCA screen with the hits from CTB analysis. Of 20 inhibitors
identified by RTCA (|z| =1.96), four showed a marginally
significant inhibiting effect in the CTB screen (false-discovery rate q
, 0.10, Figure 3b), while the other RTCA-hits did not.
Furthermore, we took advantage of an independent data set to
test the relevance of our hits. Schlabach et al. [24] had used pooled
shRNAs for knockdown of 2,924 genes and tested phenotypic
effects in four cell lines using half-hairpin barcodes and microarray
deconvolution. Out of the 20 significant inhibitors in the RTCA
screen, 11 (55%) showed inhibition in at least one of the cell lines
tested by Schlabach et al. (Figure 3b). Another four (20%) of the 20
genes identified by us had not been tested by Schlabach et al. and
the remaining five hits were not significant in the shRNA dropout
screen. This suggests that RTCA is a highly potent and sensitive
screening-tool, and demonstrates the ability to efficiently pick up
inhibitors of cell proliferation.
Next, we sought to evaluate the potential activators of cell
proliferation that had been identified in the RTCA screen. Again,
we compared the RTCA results to data obtained in the CTB-
screen as well as to the shRNA dropout screen [24]. Out of 25
siRNAs activating cell proliferation in the RTCA screen, seven
(28%) showed an activating effect also in the CTB screen (p ,
0.05, Figure 3c), and six more (24%) showed marginal activation
effects (p , 0.10, Figure S5). No activators of cell proliferation had
been reported from the shRNA dropout screen.
We next wished to investigate whether genes we found to inhibit
or activate cell proliferation would be enriched in functional
categories. To address this question we performed enrichment
analysis with Gene Ontology (GO) biological process (BP) terms
and indeed found the inhibitors enriched of GO-terms associated
with M-phase and mitosis while the activators of cell proliferation
were enriched for GO-terms such as locomotion and positive
regulation of migration (Table 1). While these GO-terms and their
association to the respective phenotypes are well in line with the
biology, the adjusted p-values are (especially in the activator case)
only indicative of marginal significance likely because of the small
number of genes in the respective categories.
In all, the cross-validation with two independent end-point
datasets and the functional enrichment suggest that RTCA is a
powerful tool that is able to identify inhibitors as well as activators
of cell proliferation with high sensitivity.
Analysis of dynamic phenotypes identified a network of
mitotic entry and exit genes as early regulators of cell
proliferation
Having identified inhibitors and activators of cell proliferation,
we next asked whether the timing of individual phenotypes could
be related to the respective functions of targeted genes. To address
this question we first clustered the hits depending on inhibiting and
activating effects and according to the time-point where the
maximal effect, i.e. the maximum z-score, had been observed
(Figure S6). Figure 4a shows inhibitors as well as activators of cell
proliferation (p , 0.05, the minimum time-window of significance
Figure 3. Dynamics of the kinome screen and the overlapping results with conventional end-point assays. (a) The mean cell-index
growth rates of all kinase knock-downs (dots) are plotted against time. The error bars (6 population standard deviation) indicate the range of CIGR
after kinase knock-down, and the dash line by fitting the mean values with a second-order linear model suggests the trend. The dynamics of negative
control and one positive control (COPB2) are shown in solid lines for comparison. (b) Overlap of constant hits modulating cell growth identified by
the RTCA system and other end-point screens. CTB stands for the cell titer blue viability assay, and Dropout refers to the published drop-out screen
with shRNA pools to identify regulators of cell growth by Schlabach et al. [24]. Inhibitors in the CTB screen having marginal significant effects (false-
discovery rate q,0.10) and having been identified in RTCA or Dropout are indicated. For activators, uncorrected p-values were employed as
otherwise no activating hits would have been obtained. In both activator and inhibitors over 50% of the hits were overlapping between the RTCA
system and the conventional end-point screens. (c) Inhibitor (left panel, false-discovery rate of q,0.10) and activator (right panel, one-sided t-test
p,0.05) hits of the CTB screen (see Figure S5 for results with one-sided t-test p,0.10). The values are shown in the percentage of non-targeting
negative controls without transformation, each in three replicates (crosses). The mean values are shown with short horizontal bars.
doi:10.1371/journal.pone.0022176.g003
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maximum effects. While inhibiting phenotypes were observed for
several genes already shortly after transfection, the first activating
effects took longer to develop. The delay of activators reaching
maximum effects compared to inhibitors is robust against
algorithms parameter selection (Figure S7).
Table 1. Function enrichment analysis of both inhibitor and activator hits of cell growth identified during the kinome screening
with the RTCA system.
Type GO ID GO Biological Process Term Count/Expected/Size BH-adj. p value
Inhibitor GO:0000279 M phase 7/0.8/50 3.9610
24
GO:0007067 Mitosis 6/0.7/50 4.9610
24
GO:0000280 Nuclear division 6/0.7/43 4.9610
24
GO:0051301 Cell division 4/0.9/55 3.0610
22
Activator GO:0007626 Locomotory behavior 4/0.5/18 3.6610
22
GO:0006935 Chemotaxis 3/0.4/14 3.8610
22
GO:0051090 Regulation of transcription factor activity 3/0.5/18 3.8610
22
GO:0030335 Positive regulation of migration 3/0.7/21 4.0610
22
GO:0007267 Cell-cell signaling 5/1.3/45 4.0610
22
See the Method section for the description of the testing procedure. Identifiers (ID) and descriptions (Term) of over-represented biological process function groups
defined by the Gene Ontology (GO) are listed. The column Count/Expected/Size shows (1) the actual count of genes labeled with the GO term/(2) expected count under
the null hypothesis of the hypergeometric model/(3) number of genes labeled with the term in all the screened genes. Benjamini-Hochberg multiple-testing correction
was applied to the p-values returned by the topGO software and the adjusted p-values are reported.
doi:10.1371/journal.pone.0022176.t001
Figure 4. Transient cell-growth modulators identified by the RTCA screen and the interaction network discovered among hits.
(a) The time-heatmap showing the kinetics of the significant transient cell-growth modulators identified during the screen (|z|.1.96, minimum time-
interval over significance level set to 3 hours), clustered into inhibitors (blue on the left side) and activators (red). The genes in each cluster are
ordered increasingly by the time at which the knockdown reaches its maximum effect on the cell-index growth rate (peak-time), indicated by the step
curve in blue or red. The color in each cell represents the time-series z-score. (b) The network regulating cellular mitosis event discovered by the
screen. Interactions among five inhibitory proteins in subfigure (a) have been reported before and are labeled in blue, the respective peak-time is
indicated in brackets. Grey nodes indicate the genes which are not present in the screened library. All three genes that were present and reported to
be proteolyzed by the APC-Cdh1 complex and therefore crucial for mitotic exit (in the blue box) were successfully identified. The edges with stunt
endings indicate inhibition, and ‘‘+p’’ along the edge indicates effects by phosphorylation. Dotted arrows indicate the involvement of gene products
in the cell cycle events.
doi:10.1371/journal.pone.0022176.g004
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transfection) was only seen in the inhibitor set of target genes and
this let us then investigate whether the respective genes would be
associated with particular gene functions. Interestingly, GO-term
analysis revealed that the genes displaying early inhibitory
phenotypic effects in the assay, i.e. WEE1, MAP3K10, CENPE,
AURKA/STK6, AKAP11 and PLK1, were enriched for GO-
terms nuclear division (p,3.9610
23, hypergeometric test, Benja-
mini-Hochberg adjustment for multiple testing), mitosis
(p,3.9610
22), M phase of mitotic cell cycle (p,3.9610
22), and
mitotic cell cycle (p,4.9610
22). In contrast to early-onset
inhibitors, genes displaying maximum effects at intermediate and
late time points (Figure S8a) were not enriched in particular GO-
terms. This could indicate that the early-onset phenotypes reflect
more direct effects (interruption of cell-cycle mechanisms) while
phenotypic changes are increasingly affected by secondary effects
at later time points.
To elucidate the biological functions and effects transient
modulators have on cell proliferation, data mining tools including
STRING [25], Reactome [26,27] as well as R packages
KEGGgraph [28] and RpsiXML [29] were used to query the
functional relationships between the hits. By mapping biochemical
protein-protein interactions among transient hits, we identified a
network of eight cell-proliferation modulators which interact
directly and regulate cell proliferation in the HeLa cell system
(Figure 4b). Most strikingly, a network of three key genes for
mitosis exit, which are rapidly proteolyzed upon induction by
APC-Cdh1: AURKA/STK6, PLK1 and CDC20 [30], were
identified. All three genes were identified as early (AURKA and
PLK1) or early-intermediate (CDC20, reaching the maximum at
32h) modulators, suggesting the sensitivity of the cell system to the
mitosis event and demonstrating the advantage of the RTCA
system to study transient and dynamic effects. The other two genes
having been associated with this pathway (PRC1 and CDCA3/
TOME-1) were not present in our screening library. Another gene
important for mitosis entry, WEE1, was discovered as the earliest
modulator, whereas WEE1s negative regulator CHEK1 (by
phosphorylation) reached its maximum effect much later (39h).
In order to validate these hits, we next deconvoluted the originally
employed pools of four siRNAs to target the indicated genes with
individual siRNAs. To this end, each of the four siRNAs contained
in the pools of the primary screen was transfected in independent
experiments. Figure S9 demonstrates that indeed most siRNAs
targeting the respective genes induced a similar phenotype as had
been observed with the pools. Normalized CI and CIGR values of
the deconvolution experiments are provided in Tables S8 and S9.
In order to prove efficient knockdown of the siRNA reagents we
performed qRT-PCR experiments after transfection of HeLa cells
with each of the individual siRNAs or with the pools. Figure S10
shows that almost all of the siRNAs led to greater than 60%
mRNA knockdown thus confirming the efficiency of RNAi.
In conclusion, the time-series cell-growth information gained
from RTCA demonstrates its power by discovering key genes
involved in cell mitotic entry and exit events as early regulators of
cell proliferation.
Discussion
Here we have described a time-resolved RNAi screen, testing
dynamic phenotypic effects that human kinases and cell-cycle
genes have on cell proliferation. By applying adequate transfor-
mation, we could show with time-dependent Z-factors that the
cell-index growth rate (CIGR) is reproducible and renders the
technology applicable for screening purposes. Consequently we
tested a human kinome siRNA library for dynamic effects of
knockdown on cell proliferation. While knockdown of the majority
of kinases indeed had slight inhibiting effects on cell proliferation,
the cells appeared to be able to overcome these effects and
continue growing once a lag phase variable in length has passed.
This let us conclude that HeLa cells are indeed sensitive to the loss
of these kinases, however, they are fit to overcome the initial effects
of the perturbations and they thus are robust from a systems point
of view. In addition, an oscillation with a period of 17 hours of
population could be observed with high amplitude at the
beginning, which becomes smaller at later time points. We assume
that the oscillation might visualize cell cycle of the cells, as the cells
might be partly synchronized by the transfection procedure. This
observation is also confirmed by the reduction of amplitude over
time as a de-synchronization of cell cycle will occur. Moreover, a
cell cycling time of 16,18 hours has been observed in HeLa
before [31], a similar frequency to that observed by us. We thus
conclude that RTCA might serve as a powerful tool to analyze cell
cycle changes.
Our screen identified genes having inhibiting as well as
activating phenotypes, with more than 50% of hits in both
categories validated by a cell titer blue assay or a published shRNA
dropout screen [24]. The overlap validates the relevance of RTCA
for screening purposes. Interestingly, our screen identified 25
genes having activating phenotypes upon knockdown on top of 20
inhibitor phenotypes. While some of these activators were only
marginally significant also in the CTB analysis and, hence, would
not have been followed up further, the shRNA screen was not able
to pick up any genes having activating phenotypes. RTCA thus
adds a new dimension in viability analysis as it allows to identify
activating phenotypes on cell proliferation in large-scale RNAi
screening with high significance.
We next analyzed the timing of inhibition as well as of
activation on cell proliferation. To this end, hits were ordered by
the time of their respective maximal effects. Strikingly, the first
inhibiting effectors became apparent shortly after transfection,
whereas activating effects took much longer to develop. The
selection of the assay time in an end-point screen thus reflects a
compromise that is likely not able to pick up all phenotypes and
thus misses a lot of useful information. GO-term analysis of the
early onset inhibitors of cell proliferation revealed an enrichment
for GO-terms such as cell cycle and mitosis, being consistent with
the transient expression of many cell cycle genes only at confined
phases of the cell cycle.
Utilizing this time-resolved data we identified transient cell
proliferation modulators and discovered a network of genes that
interact with each other and affect cell proliferation in our cell
system (Figure 4b). It would have been very difficult to pinpoint
this network with conventional end-point assays. The dynamics of
components in this network fits their biological functions well,
since we observed key cell cycle genes act as early inhibitors and
upstream signaling pathway genes as intermediate or late
activators. Strikingly we could identify and validate all the genes
known to be essential for mitosis exit that are represented in the
screening library (CDC20, AURKA/STK6 and PLK1) as early or
early-intermediate modulators.
Having determined a number of genes that are involved in
mitotic exit, this approach could be exploited in the future, e.g. for
improving cancer therapies. Specifically the targeting of the
mitotic exit is in line with current anti-mitotic development, as this
has been suggested to have enhanced therapeutic capacities than,
for example, targeting spindle assembly [32]. Therefore, the
RTCA system could potentially be used to discover compounds
that target mitotic events, since they may display early effects on
Time-Resolved Kinome RNAi Screen
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This, however, would not easily be possible with traditional end-
point assays. Furthermore, it allows investigating cell proliferation
kinetics with combinational therapy by applying multiple com-
pounds or RNAi reagents, in order to overcome transient
inhibition or activation by single component and achieve constant
regulation of cell proliferation [33].
Commonly, protein half-lives are determined in order to predict
phenotypic changes. Instead RTCA provides information at what
time after the initial perturbation the concentration of a targeted
protein has reached a critical concentration below which it is not
able any more to perform its biological function. We thus render
this a biological half-life kind of information and to have superior
content over protein half-life measurements. We are aware that
both knockdown efficiency as well as the timing of siRNA-induced
silencing are additional parameters that need to be considered in
the dynamic analysis of phenotypes. The reagents utilized for the
candidates shown in Figure 4 and leading to early phenotypic
changes had all similar knockdown efficiencies suggesting that for
those genes the timing of RNA knockdown and protein
degradation might have similarly contributed to the phenotype.
For long-lived proteins, like some structural proteins, the onset of
phenotypes could, however, be at late time-points even though
RNA knockdown was efficient already early after transfection.
While high-throughput half-life data reported a positive correla-
tion between half-life and protein size [34], our data did not verify
this association (Figure S8b). This may be due to the small set of
proteins that we identified in this screen. However, as we have
indeed found a correlation with cell cycle associated GO-terms for
early-onset inhibitors and with migration terms for activators we
conclude that the biological half-life might be more relevant than
protein size. A combination of protein and biological half-life
information would nonetheless be ideal as the effects observed with
impedance measurement do not distinguish between direct and
indirect effects. For example, GO-term enrichment was only
visible among the early-onset inhibitors, while late-onset inhibitors
did not cluster into specific functional categories. There, the effects
of events downstream of the targeted gene could become
dominant. Such consecutive order of effects could explain also
biphasic dynamic profiles as were observed for some proteins. For
example, knockdown of COPB2 (Figure 1) has been described to
result in a slow accumulation in remnant structures of ER proteins,
eventually leading to a break down of protein secretion and to
apoptosis [22]. Loss of that protein thus leads to a consecutive
order of events that culminate in cell death while the retrograde
trafficking of vesicles from the Golgi complex to the ER has not
been reported to be involved in apoptotic pathways. Integration of
protein half-life and biological half-life data would thus allow for a
direct correlation between biochemical properties of targeted
proteins and the cellular fate. Until then, time-resolved analysis of
RTCA profiles is a powerful tool to identify the timing in end-
point assays, where the maximum effect sizes could be studied
(Tables S1 and S6).
In this study we aimed to test the capabilities of the RTCA
system in large-scale RNAi screening, using a RNAi-library
targeting the human kinome and testing for dynamic phenotypic
changes. Considering the limitations of any high-throughput
screening, we performed, on top of carrying out an independent
CTB screen and integrating a literature dataset, deconvolution
experiments that successfully verified some early inhibitors (Figures
S9 and S10). More such tests might potentially validate even more
modulators having scored less significant in our intial screen, as we
found indeed most RNAi-reagents to induce milder inhibiting or
activating effects as compared to the negative control. We thus
publicize the raw data for deeper mining as well as the R/
Bioconductor package RTCA to encourage further use of the data
and the software described here.
In summary, we have carried out a human kinome RNAi
screen, using RTCA with electrical impedance as output. This
screen has validated previously identified inhibitor genes as well as
activators of cell proliferation. The high-content of data with
respect to time-resolution permits to investigate the dynamics of
RNAi phenotypes. Thereby, we identified a network of mitosis-
related genes to be among the first displaying cellular effects upon
siRNA knockdown. Our data on one hand establishes RTCA
technology as a novel tool amenable for high-throughput
screening, and on the other hand opens new avenues in the
dynamic cellular analysis of phenotypes being induced by RNAi
and likely also other perturbations.
Materials and Methods
RNAi reagents and cell culture
Human siARRAY - Protein Kinase (G-003500-02) and human
siARRAY - Cell Cycle (G-003250-02) libraries were obtained from
Dharmacon (Lafayette, US). Catalog numbers of the individual
siRNA pools are given in Table S6. Deconvolution experiments
were performed with four individual siRNA reagents that had
been pooled in the original siARRAY libraries. Order numbers
and sequences of these individual siRNAs are provided in Table
S10. Negative control siRNA reagents were siAllStars (Qiagen,
Hilden, Germany), siGENOME Non-Targeting siRNA Pool #1
(Dharmacon, Lafayette, US). All negative control siRNA reagents
were tested side by side in RTCA and CTB assays to verify their
lack of effects in the HeLa cell line employed in the experiments
(Figure S11). HeLa cells (CCL-2, ATCC) were grown in DMEM
medium supplemented with 20 mM L-Glutamine and 10x MEM/
NEAA (all Fisher Scientific, Schwerte, Germany).
Automated siRNA-Transfection and RTCA measurements
The background impedance of the real-time cell analysis system
(RTCA, xCELLigence Roche, Penzberg, Germany) E-Plates 96
was performed using the standard protocol provided in the software
with 100 mL DMEM-medium containing penicillin/streptomycin,
L-Glutamin and 10% FCS (Gibco, Darmstadt, Germany).
Following trypsination, cell concentration was determined with a
CASY-TT CellCounter (Roche, Penzberg, Germany) and 10,000
HeLa cells were seeded in every well with 100 mL additional
DMEM-Medium. E-Plates were positioned in a xCELLigence
Real-Time Cell Analyzer MP (Roche, Penzberg, Germany) and
baseline levels were recorded. 24 hours later, plates were removed
from the incubator and transfection wascarried out. Transfection of
siRNAs (human siARRAY -Protein Kinase and Cell Cycle libraries)
was carried out in a 96-well format using a Biomek FXP liquid
handling workstation (Beckman Coulter, Fullerton, US). Prior to
transfection, DMEM-medium was removed from the E-plates using
a 96 well pipetting head of the liquid handler without touching the
cells at the surface of the well bottom. Cells were washed once with
150 mL Optimem (Invitrogen, Karlsruhe, Germany) before adding
40 mL Optimem to each well. In parallel, 1.15 mL X-tremeGENE
(Roche, Penzberg, Germany) and siRNA were diluted in 20 mL
OPTIMEM, then mixed and incubated for 15 minutes before being
added to the E-Plates 96 by the liquid handlers 96 well pipetting
head, leading to a final volume of 80 mL per well and a final siRNA
concentration of 60 nM (both for pools as well as for individual
siRNAs). After 5 hours of incubation in the RTCA MP Station, the
transfection mix was removed with the liquid handler, and wells
were washed with 150 mL of DMEM-medium and then filled with
Time-Resolved Kinome RNAi Screen
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TimeCellAnalyzerMP.Cellswerethenincubatedfor90 hoursand
impedance was measured every15 minutes for 25 hours. Thereafter
impedance measurement was continued in 60 minutes intervals for
another 36 hours. A spline model was built to interpolate the time-
series cell-index into a uniform time-interval of 30 minutes between
records in tandem. Different negative controls (siAllStars, siGEN-
OME Non-Targeting siRNA Pool #1) were tested side-by-side and
displayed similar phenotypes (Figure S11).
Cell Titer Blue assay
HeLa cells were counted and set to a concentration of 1.25610
5
cells/mL. Transfection of 50 nM individual siRNAs (human
siARRAY Protein Kinase and Cell Cycle libraries) was carried out
in a 96-well format using a Biomek FXP liquid handling
workstation (Beckman Coulter, Fullerton, US). siRNAs had been
complexed with DharmaFECT transfection reagent (20 mL total
volume) for 20 minutes at room temperature, and were then mixed
with 80 mL cells and incubated for 48 hours. CellTiter-Blue
viability assays (Promega, Mannheim, Germany) were carried out
according to the supplier’s instructions measuring three replicates
of every screening plate. Five mL of CellTiter-Blue reagent were
dispensed to every well of 96well plates, plates were gently mixed
and then incubated for two hours at 37uC and 5% CO2. Then,
fuorescence intensities were measured at 485 nm (excitation) and
530 nm (emission) using a Mitras LB940 microplate reader
(Berthold Technologies, Bad Wildbad, Germany). Raw-data of
the three replicates are provided in Table S6. The results of siRNA
transfected samples were then compared to that of non-targeting
controls after log-transformation with paired t-test. Multiple-
testing correction was performed with the Benjamini-Hochberg
method [35]) to yield an estimated upper boundary of local false-
discovery rates (q-values). Of activating genes, over 300 had q-
values very close to 0.10, which we believed to be caused by the
relative small sample size and the ranking approach of the
multiple-testing correction. To avoid this potential problem, we
made the comparison between result sets by using uncorrected p-
values, while reporting data (including the statistical test results) of
the CTB assay in the Table S7. Different negative controls
(siAllStars, siGENOME Non-Targeting siRNA Pool #1) were
tested side-by-side and displayed similar phenotypes (Figure S11).
WST1 cell proliferation Assay
Cell viability was assayed using the WST-1 Cell Proliferation
Reagent (Roche, Penzberg, Germany) according to the manufac-
turer’s instructions.
qRT-PCR
Total RNA of transfected cell lines was extracted using the
Invisorb Spin cell RNA mini kit (Invitek GmbH, Berlin, Germany)
and reverse transcribed with the RevertAidTM H Minus First
Strand cDNA Synthesis kit (Fermentas, St. Leon-Rot, Germany).
Ten ng total RNA was used for each qRT-PCR reaction.
Quantitative real-time PCR was performed with probes of the
Universal Probe Library (Roche, Penzberg, Germany) for target
genes CHEK1, WEE1, PLK1, AURKA, and CDC20 (sequences
and probe numbers given in Table S11) Transfections with non-
targeting siRNAs siAllStars, siGENOME Non-Targeting siRNA
Pool #1 were analyzed as negative controls. Quantification of
amplification products was performed with a ABI Prism 7900HT
Sequence Detection System (Applied Biosystems, Weiterstadt,
Germany). Data was analyzed using the Bioconductor ddCt
package [36].
Bioinformatic and statistical data analysis
Hereafter we use following definitions: in the real-time cell
analysis (RTCA) system, the time-series cell electrical impedance
is recorded and exported as the cell index (CI) vector
x~ xs,t0,xs,t1,:::,xs,tN{1
  
in N time points (N=91 in the
kinome screen, with a measurement time point every 30 minutes
from 13h to 58h post transfection) for sample s. We denote the set
of all screened kinases and cell-cycle related genes (short as kinases
hereafter) as S, and the complete time domain as T. xs is a unit-
less and non-negative xs,T§0 ðÞ measurement of the electrical
impedance. The sample mean and variance between biological
replicates of sample s at time-point t are denoted as xs,t
and s2
xs,trespectively, and the respective standard deviation
as sxs,t. The cell-index growth rate vector is denoted as vs~
(vs,t0,vs,t1,:::,vs,tN{1), and its derivatives are denoted similarly as the
cell-index.
Transformation of Cell-Index (CI) into Cell-Index Growth
Rate (CIGR). Two main drawbacks, which prevent employing
the CI value directly in a high-throughput screening, are discussed
here. Since the CI value is positively correlated to the cell number
(Figure S1), and cell numbers vary from well to well on microtiter
plates due to the variances of initial seeding and medium change
after siRNA transfection, the CI vectors of different samples
cannot be compared directly. The manufacturer recommends the
normalization as follows: for any given sample set S, choose an
arbitrary time point (denoted as tnorm) as the normalization time





for all t. The transformed value ~ x xs,t is named as normalized cell index
by the manufacturer. It has the property that ~ x xs,tnorm:1.
Although this transformation allows to compare the cell growth
among samples, it suffers from the arbitrary selection of the tnorm.
Practically tnorm is preferentially chosen at a time point shortly
after the siRNA transfection (for instance 10 hours). However,
there is no rule defining how it should be selected and we indeed
observed effects caused by the arbitrary selection of tnorm.
Besides the arbitrariness of tnorm, using (normalized) cell-index
directly as the measure of cell-growth causes the problem of the
error propagation in the time domain T. Figure S2(a) and S2(b)
show the distributions of xs,t (mean cell-index of kinase biological
replicates) and of sxs,t (standard deviation of cell-index of kinase
biological replicates) over time for all s[S. Especially Figure S2(b)
suggests that in general the cell-index variance of biological
replicates increases along the time. This is most likely to be
explained by the error propagation in the time domain: the cell-
index measures the cell-growth in an accumulative manner, that is,
xs,tn reflects the accumulative growth for T0~ t0,:::,tn ðÞ but not the
transient cell growth status (Figure S1). Trivial departures from
earlier time points will accumulate to large variances in later time
points, and causing the increasing sxs,t in the time domain T.
Data transformation with the Cell-Index Growth Rate
(CIGR). To overcome these challenges, we introduced the Cell-
Index Growth Rate (CIGR) transformation. We define the cell-








given sample s[S and 0ƒiƒN{1. Therefore the CIGR is the
rate of change of cell index. Note that by definition the CIGR is a
Time-Resolved Kinome RNAi Screen
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~ v vs,t measures the absolute transient cell growth at t, and its sign
(direction) determines the status of cell growth: increasing (.0), in
recession (,0) and constant (=0). Analogous to the relationship
between velocity and position in physics, the CIGR measures the
transient cell-growth independent of its history, namely all the time
points that have been recorded before a new time point is
observed, once the cell number has been fixed. In the following
discussions we use v instead of v ! for simplicity.
Applied to the screening data, the CIGR transformation
calculates the point-wise first derivative for all t[T of sample
s[S (using diff function of base function in R, see the
documentation of RTCA software package for the computational
details). Figure S2(c) and S2(d) illustrate the distributions of vs,tand
svs,t of all screened samples in the same way applied to the
untransformed cell-index. Figure S2(c) suggests that the CIGR of
all screened samples are evenly distributed in the time domain T,
with the positive control (siRNA against COPB2) and the negative
control (non-targeting siAllStars) still well separated. We observe
that the variances of cell-index growth rate do not steadily increase
with the time (Figure S2(d)) but rather remain constant. We
observe, intriguingly, a moderate reduction of average sample
variances at about 30 hours after the transfection. We assume this
could have been caused by the time-lapse to establish stable siRNA
knockdowns.
Therefore the CIGR transformation is free of choosing tnorm
and prevents error propagation in the time domain. Another gain
of the transformation is that it is now possible to intuitively
compare the transient cell growth of sample s between any two
time points ti and tj,0ƒi,jƒN{1, by comparing vs,ti and vs,tj
directly.
Time-dependent Z-factor. The originally defined Z-factor
is a value between ({?,1  measuring the statistical effect size,
judging how well the negative and positive controls can be
separated in one assay and consequently whether the assay is
suitable for high-throughput screening [37]. To better utilize the
time-series information and to capture the statistical effect sizes in
the time domain, we have extended the Z-factor to a vector (tuple)
of Z-factors indexed by time. The conventional definition of
estimated Z-factor according to Zhang et al. [37] was
^ Z Z~1{
3 ^ s spz^ s sn
  
D^ m mp{^ m mnD
ð3Þ
Four parameters are required to estimate the Z-factor: the
means and standard deviations of both the positive (p) and
negative (n) controls. By extending the Z-factor into the time
domain T, the time-dependent Z-factor for t[Tis defined as
^ Z Zt~1{
3 ^ s sp,tz^ s sn,t
  
D^ m mp,t{^ m mn,tD
ð4Þ
The time-series Z-factor allows us to capture the statistical effect
size of the time-series high-throughput screenings. Since in the
RTCA we have used three positive inhibitory controls, we have
estimated the time-dependent Z-factor for each of them based on
the sample mean and standard deviation of cell-index growth rates
vs,t and illustrated them in Figure 2b. Z-scores of replicates were
summarized by the square root of the mean squared value of the
replicates (root mean square).
Average Cell-index Growth Rate. To compare the RTCA
screen with conventional end-point assays, we calculate the average








for all s[S. The average cell-index growth rate vs is equivalent to




, comparable to the results
of end-point analysis.
Since we observed effects of experimental condition’s change on
the average cell-index growth rate between different plates (Figure
S3), we performed the z-score normalization of vs in each 96-well
microtiter plate after checking the normality of the sample value
distributions [38,39]. The resulting z-scores based on the average
cell-index growth rate, zvs, are then used to perform a ranking of
the samples. Hits were selected by setting a cut-off at 61.96,
corresponding z-scores deviating about two standard deviations
from the mean (equivalent to a significance level of a=0.05
(p,0.05). Figure S4 demonstrates the robustness of the screening
by plotting the average cell-index growth rate against the screening
plates in the screening time order.
Time-series z-score of cell-index growth rate and
watershed algorithm. In order to identify transient cell-
growth regulators based on the CIGR, we have performed the





where s[Sp, Sp defines the set of all the kinase siRNA samples on
one 96-well microtiter plate. The normalities of the distribution of
vs,t were checked with quantile-quantile-plots and Shapiro-Wilk
test. The distributions of resulting time-series z-scores are shown in
the Figure S2(e). And the distribution of standard variances of
biological replicates based on the time-series z-score is shown in
the Figure S2(f).
To identify transient activators/inhibitors, three significance
levels (a=0.1, 0.05 and 0.01) and eight minimum time intervals
over significance level (1.5h-6h) were plugged in the fooding
watershed algorithm (Figures S6 and S7).
GO Enrichment Analysis. The enrichment analysis of GO-
terms was performed using both the DAVID Bioinformatics
Resources 6.7 [40] and the Bioconductor package topGO [41].
Overlapping significant GO terms are reported with the adjusted
p-value (Benjamini-Hochberg method [35]) of the results derived
from the topGO package.
Software availability. All computational and statistical
analysis was performed with R-packages of the Bioconductor
[42] platform, unless otherwise specified. To make high-
throughput data analysis with the RTCA system amenable for
public use, we implemented the open-source software package
‘RTCA’ in R on the Bioconductor platform. It imports primary
data from the RTCA system and performs data analysis and
visualization. The package is freely available at the Bioconductor
website [43].
Supporting Information
Figure S1 The cell impedance (cell-index) is positively correlated
with the cell number and the cell-index growth rate reflects the
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1,000, 3,000, 10,000 and 30,000) were seeded in the xCELLigence
system and the cell growth was recorded by measuring the
electrical impedance (cell-index). We observe the initial number of
cells is indeed correlated with higher cell-indices. In case of too
many cells seeded, the cells enter stationary phase following the
exponential growth (10,000 and 30,000 cell group) after certain
time. (b) With the cell-index growth rate transformation, the data
of subfigure (a) is illustrated as the first-degree derivative of the
cell-index curve at each time point. It is to note that the maximum
cell-index growth rate in the exponential growth is linearly
positively correlated with the cell number in a certain range (the
three dash lines indicate the CIGR at 3, 1, and 0.33,
corresponding to the initial cell number group of 30,000, 10,000
and 3,000). This suggests that the cell-index growth rate reflects
the transient cell growth rate.
(PNG)
Figure S2 Cell-index growth rate (CIGR) transformation
stabilizes the variance over time, enabling background correction
and can be normalized by the z-score method. (a) The distribution
of cell-indices in the kinome screening represented by the average
value of biological replicates (dots) and the population standard
deviation of the average values (error bars indicate 6s.d., also
applied hereafter unless otherwise specified) over time. It is
obvious that the population standard deviation of the average cell-
index increase drastically over the time, and from the cell-index it
is not easy to intuitively tell the transient cell growth status at any
given time. Green and red curves indicate the average cell-indices
of negative control siAllStars and one positive control COPB2. (b)
The distribution of sample standard variations of biological
replicates over time. Similarly to the average cell-index, the
variance between the biological replicates of individual siRNAs are
increasing along the time, reflecting the fact that the variances of
cell-index measurements accumulates along the time and the
errors are propagated. (c) The distribution of transformed cell-
index growth rates in the kinome screening, represented by the
average value of biological replicates (dots) and the population
standard deviation. The transformation stabilizes the variance
along the time, and the positive and negative control can still be
well distinguished. No plate background correction is performed
here compared to the figure 3(a) in the main text. (d) The
distribution of standardized variances of biological replicates
suggest that the transformation also stabilizes the variances of
biological replicates. We note there is a reduction of variances at
about 30 hours, and speculate it might be caused by the
establishment of the stable siRNA knockdown. (e) The normali-
zation of the cell-index growth rates using the z-score method,
showing the average z-score of the kinases over time (dots) and the
population standard deviation (error bars), also with the negative
and positive controls. (f) The distribution of standardized variances
of z-scores of biological replicates over time. The reduction of
general variability at around 30 hours is still noticeable but
weakend.
(PNG)
Figure S3 The xCELLigence technology is highly sensitive to
perturbations and, hence, requires robust normalization to
compare data from different experiments. (a) Each dot indicates
the average cell-index growth rate (CIGR) of one siRNA
knockdown sample over the measurement time. The samples
from the same parent plate of the kinome library are depicted in
the same color. For each parent plate two biological replicates
were performed. The plates are shown in the same order of being
screened, and in each 96-well plate the samples are shown in the
order from A01 (top-left) to H12 (bottom-right). Thus the figure
shows the variances of the un-normalized average cell-index
growth rate within and across the screening plates. We observe
that the variances within plates are similar, whereas there was an
abrupt rise of the average CIGR from the middle of the screening.
This was a suspected surprise: our experiment protocol showed
that exactly before the screening of the parent plate 7 (orange), the
CO2 supplier was changed, resulting in an overall increase in
measured values. This reflects the sensitivity of the xCELLigence
system and calls for correction of plate effects and normalization
procedures. (b) Normalization with the z-score method overcame
the plate effect and made samples within and across plates
comparable. Note that here we have illustrated the process to
normalize the average cell-index growth rate as example by
reducing the time-series data to one dimension, but the z-score
normalization was also applied to the whole time-series data.
(PNG)
Figure S4 Robustness of the xCELLigence screen. Eleven
parental 96-well plates with siRNAs targeting 779 kinases as well
as 80 cell cycle genes were screened in duplicate. Biological
replicates of siRNAs targeting control genes (siCOPB2, siWEE1,
siPLK1) as well as a non-targeting control (siAllStars) were present
on all plates. Each vertical string (light gray) represents one 96-well
plate, and the distribution of the normalized average cell-index
growth rates (z-score) is shown with dots: gray dots indicate
samples, siAllStars in green, COPB2 in orange, WEE1 in blue and
PLK1 in violet. It can be observed that in most screening plates
the positive controls can be well separated from the negative
controls, and the samples are evenly distributed in the range of
normalized data, demonstrating the robustness of the screen.
(PNG)
Figure S5 Marginally significant activators (significance level
p,0.10 in one-sided t-test) identified in the CTB screening.
Crosses indicate the values of siRNA transfected samples as the
percentage of negative controls in three biological replicates, and
the short horizontal bars indicate the mean value of the replicates.
(PNG)
Figure S6 The principle of the flooding watershed algorithm
and the number of hits on different parameter selections. (a) For
the sake of simplicity, we only discuss selecting the positive
regulators, the sample principle however also applies to negative
hits. To select transient cell-growth modulators, one puts water
sources in each regional minimum (blue regions) of the curves in
positive, and flood the relief from the sources. To determine
whether a cell-index growth rate curve has a transient significant
region, two parameters have to be defined: the significance level
(analogously the water level) and the minimum time window in
which the CIGR is always over the significance level, both shown
in the figure. Using a time-window instead of a single time point
helps to eliminate too transient hits (for example those ones that
are significant at only one of the 91 measurement points). It is
obvious that the higher the significance level is, or the wider the
time window is, the less hits will be identified. (b) The number of
identified cell growth regulators (both activating and inhibiting)
when adjusting the two parameters of the algorithm introduced in
(a). The time-window has been set from 1.5 hours (3 measurement
points) to 6 hours (12 measurement points), and the p value cut-off
has been set to 0.01, 0.05 and 0.10 (corresponding to the z-score
cut-off of |z|.1.64, |z|.1.96 and |z|.2.33 respectively). As
expected, the number of hits reduce as the p-cutoff becomes more
strict as well as the minimum time interval over significance
becomes longer.
(PNG)
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cell-index growth rate of inhibitors is shorter than that of
activators, independent of the parameter selection. Similar as in
the Figure S6, we tested 24 combinations of the significance level
(p,0.01, p,0.05 and p,0.10) and the time-window interval
(shortened as TW, 1.5 hour to 6 hours), and compared the
distribution of the time after transfection at which the siRNA
knockdown reaches the maximum effect on the CIGR. In all the
cases we observe the average time required by the inhibitors is
shorter than the activators (p,0.05 for all the combinations,
Student’ t-test).
(PNG)
Figure S8 Distribution of time after transfection at which the
siRNA knock-down reaches the maximum effect on the cell-index
growth rate (‘peak-time’) is linked to the biological function but not
the protein size. (a) The distribution of the ‘peak-time’ of all the
significant (p,0.05, time-window .3 h) transient modulators of
cell growth, which can be divided into three groups: early (,30
hour), intermediate (.30 and ,45 hour) and later effectors
(.45 hour). The early phase differ from the other two phases in
the way that it includes the inhibitory effectors exclusively. (b) The
time at which the siRNA knockdown reaching the maximum effect
is not significantly linearly correlated with the protein size, neither
for the activators or the inhibitors. However, as suggested by the
function enrichment analysis and the network analysis of hits
discussed in the main text, the peak-time is indeed correlated with
the biological function of the genes.
(PNG)
Figure S9 Normalized cell index for five genes identified in the
primary RTCA screen as inhibitors of cell proliferation (Figure 4).
Pools of four individual siRNAs had been transfected in the
primary screen and were deconvoluted to also test the siRNAs
(indicated with _1 to _4) individually. AllStars negative control was
included in all experiments as negative control. Dotted vertical
lines at the 8 hour timepoint indicate the time used for
normalization of data.
(PNG)
Figure S10 Efficiency of mRNA knockdown of RTCA inhibitor
hits measured by qRT-PCR. Pools of four individual siRNAs had
been transfected in the primary screen and were deconvoluted to
also test the siRNAs (indicated with _1 to _4) individually.
SiAllStars negative control as well as siGenome non-targeting
control pool #1 were included in all experiments as negative
controls. Data was normalized to the effects induced by AllStars
control. Results of three technical replicates are shown and error
bars indicate the standard deviation.
(PNG)
Figure S11 Comparison of negative control siRNAs. SiAllStars
and siGenome non-targeting control pool #1 siRNAs were
transfected into HeLa cells, and induced effects were monitored
by RTCA (a) and CTB (b) assays. Results of six biological
replicates are shown and error bars indicate the standard
deviation. In the CTB assay the indicated numbers of cells were
transfected, 10,000 cells were seeded in the RTCA assay.
(PNG)
Table S1 Normalized cell index (CI) obtained after knockdown
of 779 kinases (plates 1-10) and 80 cell cycle genes (plate 11) in the
RTCA screen. PLK1, WEE1 and COPB2 siRNAs were included
as targeting controls, while siAllStars was included as non-
targeting control on each plate. The screen was performed in
two biological replicates for every siRNA. Raw CI values obtained
for every sample at every timepoint were normalized to the CI at
8h after transfection.
(CSV)
Table S2 Kinases and cell cycle genes showing constant cell-
growth inhibiting effects in the RTCA screening. Annotation:
Rack: The parent plate in the kinome (or cell cycle) library, plates
1-10 include kinases, and 11 contains cell cycle related genes.
Well: The well position (A01-H12) on each 96-well microtitre
plate. CatalogNumber: Catalog number of the siRNA in the
library. GeneSymbol: Gene symbol annotation shipped along
with the library. EntrezGeneID: Entrez GeneID. Accession:
RefSeq accession number. Zscore: z-score of the siRNA
knockdown sample. OfficialGeneSymbol: Current official
HGNC Gene Symbol (May 2011). Identified in Ref 1. as
inhibitor of … cell line(s): In which cell line(s) were the
respective genes identified as cell-growth inhibitors in a shRNA
dropout screen (Schlabach et al, Science 319, 620 (2008)) (see the
main text for more details), ‘-’ indicates not significant in any of the
cell lines, ‘Not Tested’ indicate the gene was not tested in the
screening of reference. Identified as Inhibitor in the CTB
Screening: Whether the siRNA identified as cell-growth
inhibitors in the CTB screening (q,0.10), ‘-’ indicates not
significant in the CTB screening.
(XLS)
Table S3 Kinases and cell cycle genes showing constant cell-
growth activating effects in the RTCA screening. Annotation:
Rack: The parent plate in the kinome (or cell cycle) library, plates
1-10 include kinases, and 11 contains cell cycle related genes.
Well: The well position (A01-H12) on each 96-well microtitre
plate. CatalogNumber: Catalog number of the siRNA in the
library. GeneSymbol: Gene symbol annotation shipped along
with the library. EntrezGeneID: Entrez GeneID. Accession:
RefSeq accession number. Zscore: z-score of the siRNA
knockdown sample. OfficialGeneSymbol: Current official
HGNC Gene Symbol (May 2011). Identified as activator in
the CTB Screening: Whether the siRNA identified as cell-
growth activators in the CTB screening (one-sided t-test with
indicated p-values), ‘-’ indicates not significant in the CTB
screening.
(XLS)
Table S4 Normalized cell index growth rate (CIGR) obtained
after knockdown of 779 kinases (plates 1-10) and 80 cell cycle
genes (plate 11) in the RTCA screen. PLK1, WEE1 and COPB2
siRNAs were included as targeting controls, while siAllStars was
included as non-targeting control on each plate. The screen was
performed in two biological replicates for every siRNA. Raw CI
values obtained for every sample at every timepoint were
transformed to CIGR values as described in Materials and
Methods.
(XLS)
Table S5 Average normalized CIGR and z-scores obtained after
knockdown of 779 kinases (plates 1-10) and 80 cell cycle genes
(plate 11) in the RTCA screen. PLK1, WEE1 and COPB2 siRNAs
were included as targeting controls, while siAllStars was included
as non-targeting control on each plate. The screen was performed
in two biological replicates for every siRNA. Raw CI values
obtained for every sample at every timepoint were transformed to
normalized CIGR values and z-scores were calculated for every
siRNA as described in Materials and Methods.
(XLS)
Table S6 Raw data obtained after knockdown of 779 kinases
(plates 1-10) and 80 cell cycle genes (plate 11) in a CellTiter-Blue
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controls, while siCONTROL TOX, siCONTROL RISC-free and
siCONTROL non-Targeting siRNA pool #1 were used as non-
targeting controls on all plates. The screen was performed in three
biological replicates for every siRNA. Fluorescence intensities were
measured at 530 nm and the recorded data for each replicate are
given in columns G-I.
(XLS)
Table S7 Results obtained from the CellTiter-Blue viability
screen. PLK1, GAPDH genes were included as targeting controls,
while siCONTROL TOX, siCONTROL RISC-free and siCON-
TROL non-Targeting siRNA pool #1 were used as non-targeting
controls on all plates. The screen was performed in three biological
replicates for every siRNA. Fluorescence intensities were measured
at 530 nm and values were transformed to the natural logarithm
(ln) for each replicate (given in columns D-F). These values were
compared to the corresponding values of the non-targeting control
and a two-sided student’s t-test was performed. In column G, the
values for the t-statistics, in column H the resulting p-values are
depicted. The Benjamini-Hochberg method was used to yield an
estimated upper boundary of local false-discovery rates (q-values,
depicted in column I).
(XLS)
Table S8 Normalized cell index (CI) obtained after knockdown
of five hits (depicted in figure 4(b)) obtained from the RTCA
screen. HeLa cells were transfected in two biological replicates
with the siRNA pools used in the screen as well as with each of the
individual siRNAs contained in the pools. SiAllStars and
siGenome non-targeting siRNA pool #1 were included as non-
targeting controls. Raw CI values obtained for every sample at
every timepoint were normalized to the CI at 8h after transfection.
(XLS)
Table S9 Cell index growth rate (CIGR) obtained after
knockdown of five hits (depicted in figure 4(b)) obtained from
the RTCA screen. HeLa cells were transfected in two biological
replicates with the siRNA pools used in the screen as well as with
each of the individual siRNAs contained in the pools. SiAllStars
and siGenome non-targeting siRNA pool #1 were included as
non-targeting controls. Raw CI values obtained for every sample
at every timepoint were transformed to CIGR values as described
in Materials and Methods.
(XLS)
Table S10 Gene Symbols, order numbers (Dharmacon), and
sequences of individual siRNA reagents employed in deconvolu-
tion experiments. The same siRNAs were contained in aequimolar
concentrations also in the siRNA-pools employed in the original
RTCA as well as the CTB screens.
(XLS)
Table S11 Gene symbols, Roche UPL probe numbers and
primer sequences employed in qRT-PCR verification of knock-
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